Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 210479
Company: AUROBINDO PHARMA LTD

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ARIPIPRAZOLE ARIPIPRAZOLE 1MG/ML SOLUTION;ORAL Prescription AA No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/29/2019 ORIG-1 Approval STANDARD

Label is not available on this site.
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/05/2020 SUPPL-4 Labeling-Package Insert, Labeling-Medication Guide

Label is not available on this site.
02/04/2020 SUPPL-2 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.

ARIPIPRAZOLE

SOLUTION;ORAL; 1MG/ML
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ARIPIPRAZOLE ARIPIPRAZOLE 1MG/ML SOLUTION;ORAL Prescription No AA 203906 AMNEAL PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 1MG/ML SOLUTION;ORAL Prescription No AA 204094 APOTEX INC
ARIPIPRAZOLE ARIPIPRAZOLE 1MG/ML SOLUTION;ORAL Prescription No AA 210479 AUROBINDO PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 1MG/ML SOLUTION;ORAL Prescription No AA 204171 LANNETT CO INC
ARIPIPRAZOLE ARIPIPRAZOLE 1MG/ML SOLUTION;ORAL Prescription No AA 212870 VISTAPHARM

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English